venBio Global Strategic Fund III L.P. 13D and 13G filings for Ventyx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-30 5:25 pm Sale |
2023-01-27 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 2,720,994 4.800% |
-749,502 (-21.60%) |
Filing |
| 2022-12-15 5:00 pm Sale |
2022-12-13 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 3,470,496 6.100% |
-1,541,040 (-30.75%) |
Filing |
| 2022-09-14 5:01 pm Unchanged |
2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 5,011,536 9.950% |
0 (Unchanged) |
Filing |
| 2021-11-04 4:15 pm Purchase |
2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 5,011,536 9.950% |
5,011,536 (New Position) |
Filing |